uracil has been researched along with Carcinoma, Small Cell Lung in 3 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, SK | 1 |
| Wu, CW | 1 |
| Chang, CI | 1 |
| Keng, LT | 1 |
| Lee, MR | 1 |
| Wang, JY | 1 |
| Ko, JC | 1 |
| Liao, WY | 1 |
| Chen, KY | 1 |
| Ho, CC | 1 |
| Shih, JY | 1 |
| Yu, CJ | 1 |
| Scagliotti, G | 1 |
| Nishio, M | 1 |
| Satouchi, M | 1 |
| Valmadre, G | 1 |
| Niho, S | 1 |
| Galetta, D | 1 |
| Cortinovis, D | 1 |
| Benedetti, F | 1 |
| Yoshihara, E | 1 |
| Makris, L | 1 |
| Inoue, A | 1 |
| Kubota, K | 1 |
| Sawada, S | 1 |
| Yamashita, M | 1 |
| Komori, E | 1 |
| Suehiro, H | 1 |
| Ogino, A | 1 |
| Nogami, H | 1 |
| Segawa, Y | 1 |
| Shinkai, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-Label, Randomized, Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin in Patients Requiring Second-Line Chemotherapy for Small Cell Lung Cancer That is Refractory or Sensitive to First-Line Platinum-Based Chemotherapy[NCT01904253] | Phase 2 | 18 participants (Actual) | Interventional | 2013-07-31 | Terminated (stopped due to The preliminary data does not suggest any safety signal, but an ad hoc interim analysis showed an imbalance of PFS between the two arms) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for uracil and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Drug Combinations; Female; Humans; Male; Middle | 2016 |
2 other studies available for uracil and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2023 |
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; | 2010 |